Succinate metabolism: a new therapeutic target for myocardial reperfusion injury
- 18 May 2016
- journal article
- review article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 111 (2), 134-141
- https://doi.org/10.1093/cvr/cvw100
Abstract
Myocardial ischemia/reperfusion (IR) injury is a major cause of death worldwide and remains a disease for which current clinical therapies are strikingly deficient. While the production of mitochondrial reactive oxygen species (ROS) is a critical driver of tissue damage upon reperfusion, the precise mechanisms underlying ROS production have remained elusive. More recently it has been demonstrated that a specific metabolic mechanism occurs during ischemia that underlies elevated ROS at reperfusion, suggesting a unifying model as to why so many different compounds have been found to be cardioprotective against IR injury. This review will discuss the role of the citric acid cycle intermediate succinate in IR pathology focussing on the mechanism by which this metabolite accumulates during ischemia and how it can drive ROS production at complex I via reverse electron transport (RET). We will then examine the potential for manipulating succinate accumulation and metabolism during IR injury in order to protect the heart against IR damage and discuss targets for novel therapeutics designed to reduce reperfusion injury in patients.Funding Information
- Medical Research Council
- British Heart Foundation
This publication has 81 references indexed in Scilit:
- Fumarate Is Cardioprotective via Activation of the Nrf2 Antioxidant PathwayCell Metabolism, 2012
- Intravenous Erythropoietin in Patients With ST-Segment Elevation Myocardial InfarctionJama-Journal Of The American Medical Association, 2011
- Ischemic Preconditioning Decreases Mitochondrial Proton Leak and Reactive Oxygen Species Production in the Postischemic HeartJournal of Surgical Research, 2011
- In vivo cardioprotection by S-nitroso-2-mercaptopropionyl glycineJournal of Molecular and Cellular Cardiology, 2009
- The complex II inhibitor atpenin A5 protects against cardiac ischemia-reperfusion injury via activation of mitochondrial KATP channelsBasic Research in Cardiology, 2009
- How mitochondria produce reactive oxygen speciesBiochemical Journal, 2008
- Vitamins E and C in the Prevention of Cardiovascular Disease in MenJama-Journal Of The American Medical Association, 2008
- The endogenous mitochondrial complex II inhibitor malonate regulates mitochondrial ATP-sensitive potassium channels: Implications for ischemic preconditioningBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2008
- Mechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion InjuryPhysiological Reviews, 2008
- Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transferThe Journal of Experimental Medicine, 2007